These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 17305564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes.
    Karamloo F, Schmid-Grendelmeier P, Kussebi F, Akdis M, Salagianni M, von Beust BR, Reimers A, Zumkehr J, Soldatova L, Housley-Markovic Z, Müller U, Kündig T, Kemeny DM, Spangfort MD, Blaser K, Akdis CA.
    Eur J Immunol; 2005 Nov; 35(11):3268-76. PubMed ID: 16206231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.
    Prickett SR, Rolland JM, O'Hehir RE.
    Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sequence conservation predicts T cell reactivity against ragweed allergens.
    Pham J, Oseroff C, Hinz D, Sidney J, Paul S, Greenbaum J, Vita R, Phillips E, Mallal S, Peters B, Sette A.
    Clin Exp Allergy; 2016 Sep; 46(9):1194-205. PubMed ID: 27359111
    [Abstract] [Full Text] [Related]

  • 12. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K.
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [Abstract] [Full Text] [Related]

  • 13. [From the allergen-recognition by antibodies to new therapeutic concepts].
    Hantusch B, Jensen-Jarolim E.
    Wien Med Wochenschr; 2008 Jun; 158(1-2):13-8. PubMed ID: 18286245
    [Abstract] [Full Text] [Related]

  • 14. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children.
    Varga EM, Francis JN, Zach MS, Klunker S, Aberer W, Durham SR.
    Clin Exp Allergy; 2009 Sep; 39(9):1353-7. PubMed ID: 19538349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter, Ball T, Twardosz A, Spitzauer S, Grönlund H, Kraft D.
    Biol Chem; 1999 Sep; 380(7-8):815-24. PubMed ID: 10494830
    [Abstract] [Full Text] [Related]

  • 18. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Scheiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C.
    J Exp Med; 1996 Feb 01; 183(2):599-609. PubMed ID: 8627171
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy with peptides.
    Moldaver D, Larché M.
    Allergy; 2011 Jun 01; 66(6):784-91. PubMed ID: 21507007
    [Abstract] [Full Text] [Related]

  • 20. New strategies for allergen immunotherapy.
    Carnés J, Robinson DS.
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun 01; 2(2):92-101. PubMed ID: 19075996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.